Evidence map›Paper›PMID 26325335›Full record

ArticleOncotarget2015

Antrodia cinnamomea alleviates cisplatin-induced hepatotoxicity and enhances chemo-sensitivity of line-1 lung carcinoma xenografted in BALB/cByJ mice.

Tse-Hung Huang, Yi-Han Chiu, Yi-Lin Chan, Hang Wang, Tsung-Lin Li, Chien-Yin Liu, Cheng-Ta Yang, Tzung-Yan Lee, Jyh-Sheng You, Kuang-Hung Hsu and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Safety Assessment ofFoods (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Effect of ethanol extracts of Antrodia cinnamomea on head and neck squamous cell carcinoma cell line.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Protective Effect ofInternational journal of molecular sciences · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Tse-Hung HuangDepartment of Traditional Chinese Medicine, Chang Gung Memorial Hospital, Keelung, Taiwan.
Yi-Han ChiuDepartment of Food Science, National Taiwan Ocean University, Keelung, Taiwan.
Yi-Lin ChanDepartment of Life Science, Chinese Culture University, Taipei, Taiwan.
Hang WangDepartment of Food Science, National Taiwan Ocean University, Keelung, Taiwan.
Tsung-Lin LiGenomics Research Center, Academia Sinica, Taipei, Taiwan.
Chien-Yin LiuDepartment of Thoracic Medicine, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan.
Cheng-Ta YangDepartment of Thoracic Medicine, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan.
Tzung-Yan LeeGraduate Institute of Clinical Medicine Sciences, Chang Gung University, Taoyuan, Taiwan.
Jyh-Sheng YouGraduate Institute of Clinical Medicine Sciences, Chang Gung University, Taoyuan, Taiwan.
Kuang-Hung HsuGraduate Institute of Clinical Medicine Sciences, Chang Gung University, Taoyuan, Taiwan.
Chang-Jer WuDepartment of Food Science, National Taiwan Ocean University, Keelung, Taiwan.
Chang Gung Memorial Hospital · TWChang Gung University · TWNational Taiwan Ocean University · TWChinese Culture University · TWGenomics Research Center, Academia Sinica · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whereas cisplatin (cis-diamminedichloroplatinum II) is a first-line medicine to treat solid cancerous tumors, it often causes serious side effects. New medicines that have an equivalent or even better therapeutic effect but with free or less side effects than cisplatin are highly anticipated in cancer therapy. Recent reports revealed that Antrodia cinnamomea (AC) possesses hepatoprotective activity in addition to anticancer. In this study, we wanted to know whether AC enhances chemo-sensitivity of cisplatin and/or alleviates cisplatin-induced hepatotoxicity, as well as the underlying mechanisms thereof. Our results indicated that AC inhibited proliferation of line-1 lung carcinoma cells and rescued hepatic HepG2 cells from cisplatin-induced cell death in vitro. The fact is that AC and cisplatin synergized to constrain growth of line-1 lung carcinoma cells in BALB/cByJ mice. Quantitative real-time PCR further revealed that AC promoted expression of apoptosis-related genes, while it decreased expression of NF-κB and VEGF in tumor tissues. In liver, AC reduced cisplatin-induced liver dysfunctions, liver inflammation and hepatic apoptosis in addition to body weight restoration. In summary, AC is able to increase cisplatin efficacy by triggering expression of apoptosis-related genes in line-1 lung cancer cells as well as to protect liver from tissue damage by avoiding cisplatin-induced hepatic inflammation and cell death.

Indexed as

AnimalsAntineoplastic AgentsAntioxidantsAntrodiaApoptosis Regulatory ProteinsCell DeathCell ProliferationChemical and Drug Induced Liver InjuryCisplatinDose-Response Relationship, DrugHep G2 CellsHumansLiverLung NeoplasmsMaleMice, Inbred BALB CAntineoplastic AgentsAntioxidantsApoptosis Regulatory ProteinsCisplatinNF-kappa BPlant ExtractsVascular Endothelial Growth Factor Avascular endothelial growth factor A, mouseAntrodia cinnamomeacisplatinhepatotoxicitylung cancer

Identifiers

PMID26325335
PMCPMC4694863
OpenAlexW1912082470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.